Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study
Nicolas Epaillard, José Carlos Benítez, Teresa Gorría, Elizabeth Fabre, Mariona Riudavets, Roxana Reyes, David Planchard, Stéphane Oudard, Núria Viñolas, Noemı́ Reguart, Benjamin Besse, Laura Mezquita, Édouard Auclin
Topics & Concepts
MedicineInternal medicinePleural effusionGastroenterologyLung cancerMalignant pleural effusionPerformance statusProportional hazards modelRetrospective cohort studyCancerOncologySurgeryCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentPleural and Pulmonary Diseases